Fat Embolism

Slide 1 · Fat Embolism

From marrow injury to microvascular dysfunction

Pathogenesis · morphology · clinicopathologic correlations

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

At the end of this lecture, explain:

How fat and marrow enter vessels following tissue injury.

Why microscopic embolization differs from fat embolism syndrome.

How mechanical occlusion and toxic inflammation damage microvessels.

What the clinical manifestations and histologic pitfalls signify.

Slide 3 · Embolism describes a traveling intravascular mass

Origin of material

Blood-borne transport

Lodging in a smaller vessel

Tissue dysfunction

An embolus can be solid, liquid, or gaseous; Most are detached thrombi.

Slide 4 · Fat is one of several nonthrombotic embolic materials

Thrombotic embolus

Fat or marrow embolus

A detached intravascular thrombus

Typical source: Venous thrombus in pulmonary thromboembolism

Thrombus is the embolized material

Microscopic fat globules may travel within blood

Hematopoietic marrow tissue may accompany fat

Entry commonly follows skeletal injury

Slide 5 · Fat embolism is an anatomic phenomenon

Microscopic fat globules are present within the vascular system.

The embolized material may include bone marrow cells.

The pulmonary circulation is an important destination.

Its detection does not by itself establish clinical fat embolism syndrome.

Fat / marrow

Vessel

Pulmonary bed

Slide 6 · Long-bone fracture is the classic initiating event

Severe skeletal injury

Marrow-containing bone disrupted

Small marrow vessels injured

Fat enters the circulation

Long-bone fractures provide the characteristic clinical setting.

Slide 7 · Soft-tissue trauma and burns are less common settings

Usual setting

Less common settings

Fractures of long bones

Particularly severe skeletal injury

Marrow and vascular compartments disrupted

Soft-tissue trauma

Burn injuries

Evidence of embolization may follow tissue damage

Slide 8 · Marrow contains two potentially embolized components

Emboli can consist of adipose material with accompanying hematopoietic marrow.

Fat forms globules or droplets within vessels.

Hematopoietic elements provide a recognizable cellular component.

This mixture has an important morphologic signature.

Adipose component

Hematopoietic cells

Mixed marrow embolus

Slide 9 · Damage to marrow sinusoids creates vascular access

Bone disruption

Sinusoid / venule rupture

Marrow exposed to lumen

Intravascular material

That injuries rupture sinusoids or small venules in marrow.

Slide 10 · Marrow and fat herniate into injured vessels

Entry of marrow material

Disrupted vascular boundary allows tissue to enter blood.

The resulting embolic material may contain both fat and marrow cells.

Transport follows the direction of blood flow.

Native schematic — not histology

Slide 11 · Venous transport explains pulmonary localization

Marrow vascular spaces

Venous blood

Right side of circulation

Lung microvasculature

The source text describes fat and marrow material traveling to the lung.

Slide 12 · Emboli lodge where vessels become too small

Fat / cellular microembolus

Emboli are carried downstream from the site of origin.

Small vessel caliber can prevent passage.

Occlusion can be partial or complete.

Native schematic — not histology

Slide 13 · An embolus may contain fat without marrow cells

Fat microglobules

Marrow-containing embolus

Small lipid droplets in vascular lumina

May be difficult to demonstrate in paraffin sections

Specialized tissue preparation can be required

Lipid vacuoles and hematopoietic cells

Additional marrow elements facilitate recognition

May coexist with early thrombotic organization

Slide 14 · Microscopic fat embolization is frequent after major injury

~90%

Severe skeletal injuries

Fat embolism in approximately 90% of individuals with severe skeletal injury.

This figure describes embolization, not symptomatic syndrome.

It must not be interpreted as a syndrome incidence estimate.

Slide 15 · Fat embolization and fat embolism syndrome differ

Fat embolization

Fat embolism syndrome

Vascular presence of fat microglobules

Common after severe skeletal trauma

Can be clinically silent

Symptomatic minority of patients

Pulmonary, neurologic, and hematologic effects

Can be life-threatening

Slide 16 · A histologic finding is not equivalent to clinical disease

Two levels of inference must remain separate.

Morphologic observation: Intravascular fat or marrow.

Clinical interpretation: A multisystem syndrome after injury.

The source specifically reserves “syndrome” for symptomatic patients.

Material detected

Clinical manifestations

Syndrome assessment

Slide 17 · Four organ-system signals define the syndrome

Pulmonary insufficiency

Neurologic symptoms

Anemia

Thrombocytopenia

Slide 18 · Symptoms usually begin 1–3 days after injury

Day 0

1–3 days

Respiratory + neurologic signs

Delirium or coma

Timing is a key clinical association description.

Slide 19 · Clinical manifestations may begin suddenly

A recognizable post-injury change may include:

Tachypnea or dyspnea

Tachycardia

Irritability or restlessness

Subsequent neurologic deterioration in severe cases

Slide 20 · Tachypnea is an early respiratory manifestation

Increased respiratory rate may accompany the onset of pulmonary dysfunction.

The symptom follows a characteristic post-injury interval.

Pulmonary microcirculatory obstruction is one implicated process.

Endothelial toxicity compounds the vascular injury.

Microvascular emboli

Pulmonary dysfunction

Tachypnea

Slide 21 · Dyspnea accompanies pulmonary insufficiency

Pulmonary microvascular injury

Fat and cell aggregates can obstruct pulmonary microvessels.

Free fatty acid injury and inflammatory mediators add injury.

Dyspnea reflects clinically evident pulmonary dysfunction.

Native schematic — not histology

Slide 22 · Tachycardia may accompany early deterioration

Tachycardia with the typical onset.

It occurs alongside tachypnea and dyspnea.

It is not uniquely diagnostic of fat embolism syndrome.

It should be read within the injury-and-timing context.

Slide 23 · Irritability and restlessness are neurologic clues

Early changes

Severe progression

Irritability

Restlessness

Can appear with respiratory symptoms

Delirium

Coma

Marks neurologic deterioration

Slide 24 · Neurologic dysfunction may progress

Irritability

Restlessness

Delirium

Coma

This is a possible clinical progression, not an inevitable sequence in every patient.

Slide 25 · Cerebral microvascular obstruction contributes to symptoms

Cerebral microvascular injury

Fat microemboli can involve cerebral microcirculation.

Red-cell and platelet aggregates can contribute to occlusion.

This provides a mechanism linking emboli with neurologic injury.

Native schematic — not histology

Slide 26 · Respiratory and cerebral injury share a microvascular basis

Pulmonary circulation

Cerebral circulation

Obstruction by fat and cellular aggregates

Local endothelial injury

Clinical pulmonary insufficiency

Microvascular occlusion

Vascular injury

Neurologic dysfunction

Slide 27 · Anemia can arise from red-cell injury

Circulating fat emboli

Red-cell aggregation and/or hemolysis

Anemia

Red-cell aggregation and/or hemolysis as explanations.

Slide 28 · Platelets can adhere to circulating fat globules

Platelet adhesion / aggregation

Fat globules provide surfaces for platelet adhesion.

Subsequent platelet aggregation is described.

This contributes to a falling circulating platelet count.

Native schematic — not histology

Slide 29 · Platelet aggregation is one route to thrombocytopenia

Fat microglobule

Platelet adhesion

Platelet aggregation

Lower platelet count

Platelet consumption into aggregates is one proposed mechanism.

Slide 30 · Splenic sequestration is an alternative platelet pathway

Fat embolization

Platelet response

Splenic sequestration

Thrombocytopenia

Splenic sequestration alongside platelet aggregation.

Slide 31 · Thrombocytopenia may have two contributing mechanisms

Platelet adhesion / aggregation

Splenic sequestration

Adhesion to fat globules

Aggregation of adherent platelets

Intravascular platelet depletion

Redistribution into splenic pool

Reduction in circulating platelets

Also proposed

Slide 32 · Petechial rash is an important cutaneous clue

20–50%

Petechial rash

A diffuse petechial rash in 20%–50% of fat embolism syndrome cases.

Petechiae are useful diagnostically when present.

Absence of a rash does not exclude the syndrome.

Slide 33 · Rapid thrombocytopenia helps explain petechiae

Fat globules

Platelet adhesion / sequestration

Rapid platelet decline

Diffuse petechial rash

The source links the rash to rapid thrombocytopenia.

Slide 34 · Petechiae should be interpreted with accompanying signs

After skeletal trauma, a patient develops dyspnea, restlessness and a new diffuse petechial rash.

Which co-occurring laboratory finding does Robbins connect to the rash?

Rapid thrombocytopenia, associated with platelet adhesion/aggregation and possibly splenic sequestration.

Slide 35 · Fat embolism syndrome can be fatal

5–15%

Case fatality

Fatal outcomes in 5%–15% of fat embolism syndrome cases.

This percentage is for the symptomatic syndrome.

It must not be assigned to all patients with microemboli.

Slide 36 · Two mechanisms operate together

Mechanical obstruction

Biochemical injury

Fat globules and cellular aggregates

Lung and brain microvessel occlusion

Free fatty acid–mediated toxicity

Platelet and granulocyte activation

Slide 37 · Mechanical injury starts with intravascular blockage

Fat / cellular microembolus

Fat microemboli physically occupy small vessels.

Associated red-cell and platelet aggregates increase obstruction.

Pulmonary and cerebral vascular beds are emphasized.

Native schematic — not histology

Slide 38 · Cellular aggregates increase the embolic burden

Fat globules

Red-cell aggregates

Platelet aggregates

Small-vessel obstruction

These components can act together within the microvasculature.

Slide 39 · Biochemical injury is not simply an obstructed lumen

Fat globules

Free fatty acids released

Endothelial toxicity

Inflammatory response

The source attributes direct local toxic injury to released fatty acids.

Slide 40 · Free fatty acids amplify endothelial damage

Fatty acid endothelial toxicity

Fat globules are a source of free fatty acids.

Released fatty acids locally injure the endothelium.

This exacerbates mechanical microvascular obstruction.

Native schematic — not histology

Slide 41 · Platelet activation extends vascular injury

Fat embolization

Platelet activation

Platelet aggregates

Amplified vascular insult

Activation is part of the biochemical pathway, alongside physical occlusion.

Slide 42 · Granulocyte recruitment adds inflammatory mediators

Microvascular injury

Granulocyte recruitment

Mediator release

Additional vessel damage

Robbins specifically mentions granulocyte recruitment.

Slide 43 · Granulocytes release three named mediator classes

Mediator

Role within the textbook model

Free radicals

Part of inflammatory vascular assault

Proteases

Granulocyte-associated damaging mediators

Eicosanoids

Lipid mediators accompanying granulocyte recruitment

Slide 44 · Mechanical and biochemical pathways converge

Block the microcirculation

Damage the microcirculation

Fat, red-cell and platelet aggregates

Physical limitation of vascular flow

Free fatty acid toxicity

Activated platelets and granulocyte mediators

Slide 45 · Vascular injury links pathology to organ dysfunction

Embolic / cellular material

Vascular process

Clinical correlate

Fat + cell aggregates

Pulmonary occlusion

Pulmonary insufficiency

Fat + cell aggregates

Cerebral occlusion

Neurologic symptoms

Platelet interaction

Aggregation / sequestration

Thrombocytopenia

Red-cell effect

Aggregation / hemolysis

Anemia

Slide 46 · The pulmonary marrow embolus has three components

Marrow cells

Marrow fat

Organizing thrombus

Morphologic overview

Hematopoietic marrow cells

Vacuolated areas representing marrow fat

An associated early organizing thrombus

Interpretive vector schematic — not a tissue image

Slide 47 · Hematopoietic cells identify marrow derivation

Marrow cells

Marrow fat

Organizing thrombus

Hematopoietic component

The textbook figure shows cellular marrow elements in an embolus.

Their presence supports the interpretation of marrow embolization.

This is different from an isolated fat microglobule.

Interpretive vector schematic — not a tissue image

Slide 48 · Empty-looking vacuoles can represent extracted fat

Marrow cells

Marrow fat

Organizing thrombus

Fat-containing vacuoles

Clear spaces are described as marrow fat in the source figure.

Routine processing can remove lipids.

Vacuoles are interpreted using adjacent tissue context.

Interpretive vector schematic — not a tissue image

Slide 49 · An organizing thrombus may accompany the embolus

Marrow cells

Marrow fat

Organizing thrombus

Thrombotic component

The reference figure shows a relatively uniform red region.

Its caption identifies that region as early organizing thrombus.

The embolic complex can contain fat, marrow, and thrombogenic material.

Interpretive vector schematic — not a tissue image

Slide 50 · Routine paraffin processing can remove lipid

Fat-containing tissue

Solvent processing

Lipid dissolution

Clear spaces on section

Solvents used in routine embedding can extract fat.

Slide 51 · Why an isolated fat microglobule may be missed

Routine paraffin preparation

Specialized lipid-preserving examination

Lipids can be dissolved during processing

Isolated fat may be difficult to demonstrate

A clear vacuole is not itself a direct lipid stain

Frozen-section approach

Stain for fat

Can help demonstrate residual fat droplets

Slide 52 · Frozen sections help preserve demonstrable lipids

Suspected lipid in tissue

Frozen tissue section

Fat-preserving approach

Lipid-specific stain

Frozen sections and fat stains as specialized techniques.

Slide 53 · A stain for fat addresses the processing problem

Demonstration of isolated fat microglobules may require lipid-specific methods.

The source does not name a particular fat stain.

The critical distinction is preservation versus solvent extraction.

Technique selection is part of morphologic interpretation.

Routine processing

Lipid lost

Special fat demonstration

Slide 54 · Marrow elements can aid recognition when lipid is absent

With marrow elements

Without marrow elements

Hematopoietic cells may remain recognizable

Suggests marrow material in a vessel

Source figure illustrates this pattern

Only fat microglobules may be suspected

Routine embedding can obscure lipid

Specialized methods may be necessary

Slide 55 · Fat embolism cannot be reduced to one microscope feature

Correlate two different forms of evidence.

Morphology establishes intravascular fat or marrow material.

Clinical syndrome establishes symptomatic organ dysfunction after injury.

Textbook symptoms and the 1–3-day interval provide a clinical pattern.

Morphology and clinical syndrome are related but not identical.

Slide 56 · Compare fat emboli and thromboemboli structurally

Feature

Fat / marrow embolus

Typical thromboembolus

Embolic material

Fat droplets ± marrow cells

Dislodged thrombus

Common context

Severe skeletal injury

Venous thrombosis

Typical destination

Pulmonary microvasculature

Pulmonary arteries

Dominant teaching mechanism

Obstruction + toxic injury

Vascular obstruction

Slide 57 · Case: Deterioration after a long-bone fracture

Day 2 after severe long-bone injury: Sudden tachypnea, dyspnea, tachycardia and restlessness. Platelet count is falling.

Which linked findings make fat embolism syndrome plausible?

Compatible skeletal trigger, 1–3-day delay, pulmonary signs, neurologic signs, and thrombocytopenia.

Slide 58 · Case: Isolated fat in a lung microvessel

A lung specimen following severe skeletal trauma contains microscopic intravascular fat droplets; No respiratory syndrome was documented.

Does the histology alone establish fat embolism syndrome?

No. Fat embolization is an anatomic finding; Robbins reserves the syndrome for symptomatic patients.

Slide 59 · Case: Marrow embolus on histology

A pulmonary vessel contains hematopoietic marrow cells, clear vacuoles, and an adjacent uniform thrombus-like region.

How should the three morphologic compartments be interpreted?

Marrow cells, extracted marrow fat, and possible early organizing thrombus—matching the textbook’s figure description.

Slide 60 · Case: The negative routine fat stain problem

After routine paraffin embedding, an embolus suspected of containing fat no longer shows intact lipid droplets.

What tissue-processing principle explains this limitation?

Organic solvents can dissolve fat. Frozen sections and stains for fat may be needed to demonstrate microglobules.

Slide 61 · Common interpretive errors

Misstatement

Textbook-consistent interpretation

~90% develop clinical syndrome

~90% may have fat emboli after severe skeletal injury

A rash is mandatory

Petechiae appear in 20%–50% of cases

Pure mechanical blockage explains all injury

Fatty acids and inflammatory mediators add damage

No lipid in paraffin excludes fat embolism

Routine processing may dissolve lipid

Slide 62 · Mechanism-to-phenotype synthesis

Starting event

Intermediate mechanism

Result

Skeletal injury

Fat / marrow into blood

Emboli to lung

Fat + cell aggregates

Lung / brain microvessel obstruction

Respiratory / neurologic effects

Fatty acid release

Toxic endothelial injury

Inflammatory vascular damage

Platelet / RBC effects

Aggregation, sequestration or hemolysis

Low platelets / anemia

Slide 63 · Five facts to retain

The defining clinicopathologic structure is:

Fat embolization is frequent after severe skeletal trauma.

Only a minority develop the symptomatic syndrome.

The usual interval to onset is 1–3 days.

Obstruction and biochemical vascular injury coexist.

Histologic fat detection is altered by routine solvent processing.